ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy
Lung Cancer, 05/04/2012
Das M et al. – Low expression of ERCC1 on circulating tumor cell correlates with Progression–free survival in patients with metastatic non–small–cell lung cancer receiving platinum–based therapy.



